Avril 2020



A Monoclonal Against Interleukin 13 works in Atopic dermatitis
Dupilumab as a Novel Therapy for Bullous Pemphigoid
Netherton Syndrome: A Staphylococcal Dysbiosis
Healing of Buruli Ulcer Linked to Anti Toxin Antibodies
STAR Particles: A Revolution In Topical Drug & Vaccine Delivery?

FOCUS (page 8)
The Come-Back of Phototherapy: New targets New Dosing
Eczema in Patients on Biologics For Psoriasis: A Need to Develop a Detailed Understanding
Dyshidrotic Eczema During Secukinumab for Plaque Psoriasis
Psoriasis in Dupilumab Treated Atopic Dermatitis
Acute Onset of Psoriasis in Atopic Dermatitis Treated with Dupilumab
Management of Residual Psoriasis in Patients on Biologic Treatment
A New Cytokine-Independent Target in Therapy of Psoriasis and Psoriatic Arthritis

SKIN & COVID19 (page 12)
Minimally invasive autopsies: NO VIRUS IN SKIN?
Patients on Biologics & COVID-19: A DIFFICULT CHOICE
Skin Damage Among Healthcare Workers Managing Coronavirus Disease-2019
Skin Lesions From Protective Equipment May Drive Viral Transmission Through Face Touching
Purpuric Rash In a Patient With COVID-19
Many COVID-19 Infected Pa- tients Have a Rash at The Onset
How Did Chinese Dermatologists Cope With SARS-CoV-2

COVID-19 & Skin Gazette (page 15)
Covid-19 infection in a woman on Tofacitinib for Alopecia Areata

SGDV / SSDV (page 17)
Vorprogramm 102. Jahresversammlung der SGDV
/ Pré-programme 102ème Réunion annuelle de la SSDV

Reports (page 34)
Basal cell carcinoma: a common diagnosis in uncommon location mimicking other conditions
"Therapy-refractory" scabies: nuisance for everybody

Photo of the month (page 40)

Terminologie (page 44)

Industrie (page 45)
Ixekizumab stark wirksam bei Plaque-Psoriasis: Langanhaltend über 5 Jahre bei schnellem Therapieansprechen von Kopf bis Fuss